[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0751132T3 - Pyridazinonderivater og fremgangsmåder til fremstilling af samme - Google Patents

Pyridazinonderivater og fremgangsmåder til fremstilling af samme

Info

Publication number
DK0751132T3
DK0751132T3 DK96110412T DK96110412T DK0751132T3 DK 0751132 T3 DK0751132 T3 DK 0751132T3 DK 96110412 T DK96110412 T DK 96110412T DK 96110412 T DK96110412 T DK 96110412T DK 0751132 T3 DK0751132 T3 DK 0751132T3
Authority
DK
Denmark
Prior art keywords
preparing
processes
same
pyridazinone derivatives
pyridazinone
Prior art date
Application number
DK96110412T
Other languages
Danish (da)
English (en)
Inventor
Michihisa Yato
Shinsuke Nishiyama
Akihiko Ishida
Harutami Yamada
Fumikazu Okumura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0751132T3 publication Critical patent/DK0751132T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Couplings Of Light Guides (AREA)
DK96110412T 1995-06-27 1996-06-27 Pyridazinonderivater og fremgangsmåder til fremstilling af samme DK0751132T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16062095 1995-06-27
JP1985996 1996-02-06

Publications (1)

Publication Number Publication Date
DK0751132T3 true DK0751132T3 (da) 2000-11-13

Family

ID=26356726

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96110412T DK0751132T3 (da) 1995-06-27 1996-06-27 Pyridazinonderivater og fremgangsmåder til fremstilling af samme

Country Status (21)

Country Link
US (2) US5698554A (de)
EP (1) EP0751132B1 (de)
KR (1) KR970061873A (de)
CN (1) CN1144802A (de)
AR (1) AR002602A1 (de)
AT (1) ATE195937T1 (de)
AU (1) AU694955B2 (de)
BG (1) BG62768B1 (de)
CA (1) CA2179939A1 (de)
DE (1) DE69610036T2 (de)
DK (1) DK0751132T3 (de)
ES (1) ES2151110T3 (de)
GR (1) GR3034910T3 (de)
HU (1) HUP9601766A3 (de)
IL (1) IL118631A (de)
MY (1) MY132263A (de)
NO (1) NO311084B1 (de)
PT (1) PT751132E (de)
RU (1) RU2131419C1 (de)
SG (1) SG46741A1 (de)
TW (1) TW432052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235911C (en) * 1997-05-27 2003-07-29 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
KR20030061051A (ko) * 2002-01-07 2003-07-18 대한민국 (경상대학교 총장) 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa
CN101443317B (zh) * 2006-03-17 2011-07-06 住友化学株式会社 哒嗪酮化合物及其作为除草剂的用途
DK2069312T3 (da) * 2006-07-25 2013-02-04 Cephalon Inc Pyridazinonderivater
MX2010005070A (es) * 2007-11-15 2010-05-24 Angeletti P Ist Richerche Bio Derivados de piridazinona como inhibidores de parp.
WO2011116287A1 (en) * 2010-03-19 2011-09-22 Purdue Research Foundation Ccr5 modulators for treating hiv
RU2608109C2 (ru) 2010-11-05 2017-01-13 Синомикс, Инк. Соединения, пригодные в качестве модуляторов trpm8
US8778941B2 (en) 2011-06-24 2014-07-15 Amgen Inc. TRPM8 antagonists and their use in treatments
CN103906733A (zh) 2011-06-24 2014-07-02 安姆根有限公司 Trpm8拮抗剂及其在治疗中的用途
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
JP6865743B2 (ja) 2015-10-01 2021-04-28 フィルメニッヒ インコーポレイテッドFirmenich Incorporated Trpm8の活性調節因子として有用な化合物
MY190795A (en) 2016-04-15 2022-05-12 Abbvie Inc Bromodomain inhibitors
US11192900B2 (en) * 2018-10-30 2021-12-07 Nuvation Bio Inc. Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
EP4248973A3 (de) 2018-11-06 2023-12-06 Edgewise Therapeutics, Inc. Pyridazinonverbindungen und ihre verwendungen
KR102677015B1 (ko) 2019-07-02 2024-06-19 누베이션 바이오 인크. Bet 억제제로서의 헤테로시클릭 화합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6053022B2 (ja) * 1977-04-07 1985-11-22 ウェルファイド株式会社 ピリダジノン誘導体
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
KR860007219A (ko) * 1985-03-12 1986-10-08 베쩰, 좀머 설포닐아미노에틸 화합물의 제조방법
DE3508692A1 (de) 1985-03-12 1986-09-18 Dr. Karl Thomae Gmbh, 7950 Biberach 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JPS63145272A (ja) * 1986-12-09 1988-06-17 Morishita Seiyaku Kk 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2105067C (en) 1991-03-01 2002-05-14 Kiyoshi Yoshida Indan derivative and thromboxane antagonist containing the same
JP2616584B2 (ja) * 1992-07-02 1997-06-04 田辺製薬株式会社 ピリダジノン誘導体及びその製法
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same
JP2757353B2 (ja) * 1993-12-28 1998-05-25 田辺製薬株式会社 インダン誘導体、その製法及びその合成中間体
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same

Also Published As

Publication number Publication date
DE69610036T2 (de) 2001-04-12
TW432052B (en) 2001-05-01
EP0751132A1 (de) 1997-01-02
BG62768B1 (bg) 2000-07-31
KR970061873A (ko) 1997-09-12
NO962643D0 (no) 1996-06-21
GR3034910T3 (en) 2001-02-28
AU694955B2 (en) 1998-08-06
NO311084B1 (no) 2001-10-08
SG46741A1 (en) 1998-02-20
PT751132E (pt) 2000-12-29
AR002602A1 (es) 1998-03-25
IL118631A (en) 2002-05-23
HUP9601766A3 (en) 1998-04-28
NO962643L (no) 1996-12-30
ATE195937T1 (de) 2000-09-15
AU5622196A (en) 1997-01-09
HUP9601766A2 (en) 1997-02-28
CA2179939A1 (en) 1996-12-28
EP0751132B1 (de) 2000-08-30
BG100684A (bg) 1997-03-31
US5698554A (en) 1997-12-16
ES2151110T3 (es) 2000-12-16
CN1144802A (zh) 1997-03-12
HU9601766D0 (en) 1996-08-28
MY132263A (en) 2007-09-28
US5808065A (en) 1998-09-15
IL118631A0 (en) 1996-10-16
DE69610036D1 (de) 2000-10-05
RU2131419C1 (ru) 1999-06-10

Similar Documents

Publication Publication Date Title
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
BR9703332A (pt) Derivados de piridazinona
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
DK80593D0 (da) Fremgangsmaade og anlaeg til udvejning af genstandsportioner
NO985329D0 (no) FremgangsmÕte for Õ fremstille koplymerer og blandinger inneholdende det samme
DK0936873T3 (da) Coatet konfektureprodukter og fremgangsmåder til fremstilling af samme
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
DK0751132T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
DK0677321T3 (da) Slangeenhed og fremgangsmåde til fremstilling af samme.
DK0676438T3 (da) Orienteret film, der er let at spalte, og fremgangsmåde til fremstilling af den
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
NO950174D0 (no) PLL syntetiserer og fremgangsmåte for styring av samme
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK0909270T3 (da) Fremgangsmåde til fremstilling af 2,4-dihydroxypyridin og 2,4-dihydroxy-3-nitropyridin
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0974268T3 (da) Bifidobakterie-fermenteret mælk og fremgangsmåde til produktion af samme
DK0625586T3 (da) Konstruktionselement og fremgangsmåde til fremstilling af dette
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
NO974058D0 (no) Fargestoff og framgangsmåte for framstilling av samme
NO941997D0 (no) Fremgangsmåte for belegging av fröplante og system for fremgangsmåtens utförelse
DK1020524T3 (da) Mutant bioluminescerende protein og fremgangsmåde til fremstilling af det mutante bioluminescerende protein
DK1524268T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
DK1032559T3 (da) Aminoalkylphenolderivater til behandling af depression og hukommelsessvigt